Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Keros Therapeutics Inc?

Accepted Answer

Según el último estado financiero (Form-10K), Keros Therapeutics Inc tiene un total de activos de $615, una ganancia neta loss de $-187

Question 2

¿Cuáles son los ratios financieros clave para KROS?

Accepted Answer

El ratio corriente de Keros Therapeutics Inc es 13.97, el margen neto es -6,233.33, las ventas por acción son $0.08.

Question 3

¿Cómo se desglosan los ingresos de Keros Therapeutics Inc por segmento o geografía?

Accepted Answer

Keros Therapeutics Inc largest revenue segment is Therapeutics for Hematological, Pulmonary and Cardiovascular Disorders, at a revenue of 3,550,000 in the most earnings release.For geography, United States is the primary market for Keros Therapeutics Inc, at a revenue of 3,550,000.

Question 4

¿Es rentable Keros Therapeutics Inc?

Accepted Answer

no, según los últimos estados financieros, Keros Therapeutics Inc tiene una ganancia neta loss de $-187

Question 5

¿Tiene Keros Therapeutics Inc alguna deuda?

Accepted Answer

yes, Keros Therapeutics Inc tiene una deuda de 44

Question 6

¿Cuántas acciones en circulación tiene Keros Therapeutics Inc?

Accepted Answer

Keros Therapeutics Inc tiene un total de acciones en circulación de 40.55

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	232	3	0	0	20	0
Revenue Growth (YoY)	--	--	--	-100%	--	-100%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	45	40	34	27	21	12
Research & Development	187	173	135	87	55	33
Operating Expenses	232	214	170	114	76	46
Other Non Operating Income (Expenses)	0	0	2	10	0	1
Pretax Income	26	-187	-152	-104	-56	-45
Income Tax Expense	8	0	0	0	2	0
Net Income	18	-187	-152	-104	-58	-45
Net Income Growth	-111%	23%	46%	79%	28.99%	275%
Shares Outstanding (Diluted)	40.61	37.43	29.44	25.24	23.33	15.51
Shares Change (YoY)	12%	27%	17%	8%	50%	-19%
EPS (Diluted)	0.46	-5	-5.19	-4.15	-2.52	-2.94
EPS Growth	-110%	-4%	25%	65%	-14%	359%
Free Cash Flow	53	-162	-126	-71	-63	-37
Free Cash Flow Per Share	1.3	-4.32	-4.27	-2.81	-2.7	-2.38
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	-7,000%	0%	0%	-280%	0%
Profit Margin	7.75%	-6,233.33%	0%	0%	-290%	0%
Free Cash Flow Margin	22.84%	-5,400%	0%	0%	-315%	0%
EBITDA	1	-209	-169	-114	-56	-46
EBITDA Margin	0.43%	-6,966.66%	0%	0%	-280%	0%
D&A For EBITDA	1	1	0	0	0	0
EBIT	0	-210	-169	-114	-56	-46
EBIT Margin	0%	-7,000%	0%	0%	-280%	0%
Effective Tax Rate	30.76%	0%	0%	0%	-3.57%	0%

Keros Therapeutics Inc (KROS) Price

KROS Stock Price Chart

KROS Income

Follow-Up Questions